The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
D-Wave's commercial momentum is accelerating, but the gap between bookings, recurring revenue, and valuation could decide what comes next for the stock.
AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.
One trades on steady cash generation and regulated returns, while the other bets on explosive demand for equipment. Their financial profiles tell starkly different stories.
Securing access to critical minerals is vital for U.S. national security. Which of these stocks is the best way to play the world-shaping minerals shift?
Disney is profitable, growing, and buying back billions in stock. Roblox is burning cash and asking investors to wait on a long-term platform bet. Which is the better use of your capital right now?
Nvidia's latest quarter shows AI demand remains extraordinary, but the numbers beneath the earnings beat reveal why the next stage of growth could be much harder to deliver.
Darby disposed of 27% of his direct equity stake at prices ranging from $47.24 to $48.54 per share, leaving him with 53,850 shares valued at $2.6 million.
IREN's AI ambitions are getting a real-world test. See what Horizon 1 changes, what must happen next, and why repeatable execution could matter more than another blockbuster contract.
The Vanguard Morningstar Growth ETF is a great fund for investors who want megacap growth exposure, but it doesn't need to be paired with its S&P 500 counterpart.
One company is returning billions to shareholders while demand for its products continues to accelerate. The other is still years away from making money on the cars it sells.
Redwire is scaling quickly, but one financial test may determine how much of that growth ultimately reaches shareholders. The latest numbers reveal what investors should watch next.
CAVA's rapid expansion and surging traffic put it in a different growth category than Chewy's steady but modest pet retail business. But is the premium price tag worth it?
CrowdStrike commands a premium valuation that its growth and free cash flow continue to justify. UiPath just turned consistently profitable but is still working to convince investors that the growth story is intact.
One is the fastest-growing connectivity play in AI infrastructure. The other has Nvidia's backing and a decade of hyperscaler relationships. Which belongs in your portfolio?
Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value and quality.
CrowdStrike is generating record revenue and free cash flow while C3.ai works to rebuild from the ground up. The gap in execution between these two companies tells the whole story.
Ford is cheap, profitable, and raising its outlook. Tesla is expensive, burning cash, and betting everything on a future that hasn't arrived yet. Which risk is worth taking?
